TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Emcure Pharmaceuticals Ltd.

EMCURE on NSE · 19 Nov 2026

NIFTY 500

2,344.70 ▲ +0.42 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Quarterly results

The last 10 quarters, and the day after each.

QuarterRevenueYoYProfitYoYMarginEPSResult dateNext-day move
Q2 FY27 (Jul-Sep 2026)2,820+24.3 % 326+33.7 %11.5 %17.16 03 Nov 2026+9.3 %
Q1 FY27 (Apr-Jun 2026)2,580+22.8 % 294+42.1 %11.4 %15.50 06 Aug 2026-1.1 %
Q4 FY26 (Jan-Mar 2026)2,470+16.7 % 243+28.8 %9.9 %12.84 05 May 2026-1.8 %
Q3 FY26 (Oct-Dec 2025)2,363+20.4 % 231+50.0 %9.8 %12.16 04 Feb 2026+1.9 %
Q2 FY26 (Jul-Sep 2025)2,270+13.4 % 243+25.1 %10.7 %12.85 11 Nov 2025-2.4 %
Q1 FY26 (Apr-Jun 2025)2,101+15.7 % 207+43.6 %9.9 %10.92 07 Aug 2025-1.5 %
Q4 FY25 (Jan-Mar 2025)2,116- 189-8.9 %9.97 22 May 2025+10.0 %
Q3 FY25 (Oct-Dec 2024)1,963- 154-7.8 %8.12 06 Feb 2025+2.8 %
Q2 FY25 (Jul-Sep 2024)2,002- 195-9.7 %10.33 08 Nov 2024-3.2 %
Q1 FY25 (Apr-Jun 2024)1,815- 144-7.9 %7.95 13 Aug 2024+0.5 %

₹ cr, consolidated; EPS in ₹ a share, as reported. YoY: against the same quarter last year. Next-day move: the share's move on the first trading day after the result. A dash means the figure is not available; nothing is estimated.

Financial years

The years these quarters add up to.

Year to MarchRevenueYoYProfitYoYMarginEPS
FY269,204+16.6 % 924+35.7 %10.0 %48.77
FY257,896- 681-8.6 %36.37

A year is the sum of its four reported quarters, shown only when all four are available; it can differ a little from the audited annual figures. Results start from Q1 FY25 (Apr-Jun 2024).

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in